Biosimilars and Biobetters Conference 2015

With Europe leading the way in the field of Biosimilar development and accounting for 80% of global spending on these molecules, the 2015 agenda will feature sessions on all areas including of product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing and reimbursement through to emerging markets and global developments.

Benefits of attending:
- Hear the latest on the evolving regulatory biosimilar landscape and review the guidelines
- Gain understanding on the barriers being faced for market access and commercialisation of products through case-study led presentations
- Focus on the global market developments with case studies on the emerging markets of biosimilars and assessing the trends we are currently seeing
- Assess and review in-depth protein characterisation and analytical comparability to efficiently and effectively collect data

Speakers:
Albin James Nelson, Alan Sheppard, Bracha Timan, Chris Teale, Christopher Stothers, Dirk Kreder, Jennifer Sklenar, Julian Morris and many more…